These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2209837)

  • 1. A pilot randomized control trial of proglumide (a gastrin receptor antagonist) in advanced colorectal cancer.
    Morris DL; Charnley RM; Ballantyne KC; Jones J
    Eur J Surg Oncol; 1990 Oct; 16(5):423-5. PubMed ID: 2209837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personal experience on treatment of colorectal liver metastases: a multidisciplinary approach.
    Mancini R; Ettorre G; Vennarecci G; Sperduti I; Garufi C; Esposito A; Cosimelli M
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):213-7. PubMed ID: 16767934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer metastases: surgical indications and multimodal approach.
    Ciferri E; Bondanza GS; Municinò O; Castagnola M; Gazzaniga GM
    Hepatogastroenterology; 2003; 50(54):1836-46. PubMed ID: 14696416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgeon's awareness of the synchronous liver metastases during colorectal cancer resection may affect outcome.
    Hamady ZZ; Malik HZ; Alwan N; Wyatt JI; Prasad KR; Toogood GJ; Lodge JP
    Eur J Surg Oncol; 2008 Feb; 34(2):180-4. PubMed ID: 17983724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The chemoradiotherapy of advanced colorectal carcinoma--the results and toxicity in a pilot study with 44 patients].
    Brockmann WP; Wiegel T; Sommer K; Steiner P; Hübener KH
    Strahlenther Onkol; 1993 Feb; 169(2):107-13. PubMed ID: 8451725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after hepatic resection in metastatic colorectal cancer: a population-based study.
    Cummings LC; Payes JD; Cooper GS
    Cancer; 2007 Feb; 109(4):718-26. PubMed ID: 17238180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The relation between serum carcinoembryonic antigen (CEA) and response to chemotherapy in patients with advanced colorectal cancer].
    Shimano T; Monden T; Morimoto H; Mori T
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):423-8. PubMed ID: 2321973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of CEA levels and positive cytology in peritoneal washings in patients with colorectal cancer.
    Kanellos I; Zacharakis E; Kanellos D; Pramateftakis MG; Betsis D
    Colorectal Dis; 2006 Jun; 8(5):436-40. PubMed ID: 16684089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update of carcinoembryonic antigen radioimmunotherapy with (131)I-labetuzumab after salvage resection of colorectal liver metastases: comparison of outcome to a contemporaneous control group.
    Liersch T; Meller J; Bittrich M; Kulle B; Becker H; Goldenberg DM
    Ann Surg Oncol; 2007 Sep; 14(9):2577-90. PubMed ID: 17570017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial.
    Schulze T; Kemmner W; Weitz J; Wernecke KD; Schirrmacher V; Schlag PM
    Cancer Immunol Immunother; 2009 Jan; 58(1):61-9. PubMed ID: 18488223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results.
    Liersch T; Meller J; Kulle B; Behr TM; Markus P; Langer C; Ghadimi BM; Wegener WA; Kovacs J; Horak ID; Becker H; Goldenberg DM
    J Clin Oncol; 2005 Sep; 23(27):6763-70. PubMed ID: 16170184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the gastrin receptor antagonist proglumide on survival in gastric carcinoma.
    Harrison JD; Jones JA; Morris DL
    Cancer; 1990 Oct; 66(7):1449-52. PubMed ID: 2207995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Final results of a randomized clinical trial of adjuvant intraportal chemotherapy for colorectal cancer: Intraportal Chemotherapy for Colorectal Cancer Group].
    Yamamura T; Yabe K; Oka H; Kouzuma T; Kawahara H; Wakayama T; Sugiura A; Hagiwara M; Ohdate K; Miyajima N; Maeda C; Okamura R; Miyahara T; Moriyama Y; Yamaguchi S; Gunji A;
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1765-71. PubMed ID: 12402427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver metastases of colorectal cancer: medical treatments.
    Pasetto LM; Rossi E; Monfardini S
    Anticancer Res; 2003; 23(5b):4245-56. PubMed ID: 14666634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P53 overexpression in colorectal metastases confined to the liver and outcome of liver resection.
    Heisterkamp J; van Bommel J; Hop WC; Tilanus HW; Zondervan PE; IJzermans JN
    Hepatogastroenterology; 1999; 46(30):3109-14. PubMed ID: 10626170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Can the occurrence of extrahepatic metastases in regional chemotherapy of the liver be prevented by adding systemic chemotherapy? A randomized multicenter study].
    Hottenrott C; Lorenz M
    Z Gastroenterol Verh; 1989 Jul; 24():199-201. PubMed ID: 2474952
    [No Abstract]   [Full Text] [Related]  

  • 17. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
    Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
    Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Status of portal perfusion in colorectal cancer. Swiss Study Group for Clinical Cancer Research].
    Metzger U; Laffer U; Egeli R; Arma S; Aeberhard P; Barras JP; Martinoli S; Müller W; Castiglione M; Schroeder R
    Chirurg; 1994 Jun; 65(6):509-13. PubMed ID: 8088206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions.
    Kato T; Yasui K; Hirai T; Kanemitsu Y; Mori T; Sugihara K; Mochizuki H; Yamamoto J
    Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S22-31. PubMed ID: 14530655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903.
    Posner MC; Niedzwiecki D; Venook AP; Hollis DR; Kindler HL; Martin EW; Schilsky RL; Goldberg RM; Mayer RJ
    Ann Surg Oncol; 2008 Jan; 15(1):158-64. PubMed ID: 18008108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.